Fluidigm Corporation Announces Technical Breakthrough That Solves Fundamental Obstacle with Microfluidics in Life Science

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation, the leader in integrated fluidic circuits (IFCs), has achieved another first in microfluidics—a matrix chip architecture that enables both a high density of experiments (2,304 per chip) and effective mixing of nano-volume scale fluids. This advance is one of several that have established IFCs as a new paradigm for life-science research, much as the integrated circuit revolutionized electronics. The new chip will allow Fluidigm to enter end-point PCR detection markets, such as SNP genotyping, which require both high-throughput and fully mixed reaction components.